SetPoint Medical

SetPoint Medical is sponsoring RESET RA , the US pivotal trial of its novel arthritis therapy, with $64m raised in a recent preferred stock financing. SetPoint developed a proprietary vagus nerve st

While investors and executives in the health care products industry have not remained untouched by the COVID-19 pandemic, they have not been as surprised as people might assume about the situation tha

To spotlight the most innovative start-ups in the medtech space as we move into 2020, Medtech Insight is reflecting on 2019 to see which companies piqued the highest interest among readers. Our most

SetPoint Medical Corp. expects to address a variety of chronic autoimmune diseases with a unique bioelectric implant. In the early 2000s, company co-founder Kevin Tracey, a neurosurgeon at the Feinst